Klinik für Rhythmologie

Delacrétaz E, Brenner R, Schaumann A, Eckardt L, Willems S, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, Kuck KH; For the Vtach Study Group.Catheter Ablation of Stable Ventricular Tachycardia Before Defibrillator Implantation in Patients with Coronary Heart Disease (VTACH): An On-Treatment Analysis. J Cardiovasc Electrophysiol. 2012 Dec 17. doi: 10.1111/jce.12073. [Epub ahead of print] Frommeyer G, Rajamani S, Grundmann F, Stypmann J, Osada N, Breithardt G, Belardinelli L, Eckardt L, Milberg P. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia. J Card Fail. 2012 Dec;18(12):939-49. doi: 10.1016/j.cardfail.2012.10.017. Samol A, Masin M, Gellner R, Otte B, Pavenstädt HJ, Ringelstein EB, Reinecke H, Waltenberger J, Kirchhof P. Prevalence of unknown atrial fibrillation in patients with risk factors.  Europace<//span>. 2012 Dec 20. Köbe J, Wasmer K, Reinke F, Eckardt L. Deactivation of implanted cardioverter-defibrillators at the end of life in the setting of an outpatient clinic. J Palliat Med. 2012 Dec;15(12):1291. doi: 10.1089/jpm.2012.0341. No abstract available. Frommeyer G, Eckardt L, Breithardt G. Panic attacks and supraventricular tachycardias: the chicken or the egg? Neth Heart J. 2013 Feb;21(2):74-7. doi: 10.1007/s12471-012-0350-2. Frommeyer G, Schmidt M, Clauß C, Kaese S, Stypmann J, Pott C, Eckardt L, Milberg P. Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. Eur J Heart Fail. 2012 Dec;14(12):1322-31. doi: 10.1093/eurjhf/hfs163. Epub 2012 Oct 25. Dechering DG, Kochhäuser S, Wasmer K, Zellerhoff S, Pott C, Köbe J, Spieker T, Piers SR, Bittner A, Mönnig G, Breithardt G, Wichter T, Zeppenfeld K, Eckardt L. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Oct 13. doi:pii: S1547-5271(12)01209-X. 10.1016/j.hrthm.2012.10.019. [Epub ahead of print] Frommeyer G, Kaiser D, Uphaus T, Kaese S, Osada N, Rajamani S, Belardinelli L, Breithardt G, Eckardt L, Milberg P. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits. Heart Rhythm. 2012 Dec;9(12):2051-8. doi: 10.1016/j.hrthm.2012.08.029. Epub 2012 Aug 28. Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S, Löher A, Amler S, Lichtenberg A, Winter J, Eckardt L. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: A multicenter case-control study. Heart Rhythm. 2013 Jan;10(1):29-36. doi: 10.1016/j.hrthm.2012.09.126. Epub 2012 Sep 29. Zumhagen S, Stallmeyer B, Friedrich C, Eckardt L, Seebohm G, Schulze-Bahr E. Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy. Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):211-9. doi: 10.1007/s00399-012-0232-8. Epub 2012 Sep 21. Frommeyer G, Pott C, Eckardt L, Schulze-Bahr E. [Catecholaminergic polymorphic ventricular tachycardia]. Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):231-6. doi: 10.1007/s00399-012-0224-8. Epub 2012 Sep 18. German. Wasmer K, Köbe J, Dechering D, Milberg P, Pott C, Vogler J, Stypmann J, Waltenberger J, Mönnig G, Breithardt G, Eckardt L. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus. Clin Res Cardiol. 2013 Feb;102(2):139-44. doi: 10.1007/s00392-012-0507-4. Epub 2012 Sep 15. Kaese S, Verheule S. Cardiac electrophysiology in mice: a matter of size. Front Physiol. 2012;3:345. doi: 10.3389/fphys.2012.00345. Epub 2012 Sep 5. Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S. Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.  Circ Arrhythm Electrophysiol. 2012 Oct;5(5):913-9. doi: 10.1161/CIRCEP.112.973339. Epub 2012 Aug 23. Israel CW, Bänsch D, Böcker D, Butter C, Chun J, Deisenhofer I, Eckardt L, Geller JC, Hanke T, Klingenheben T, Piorkowski C, Schumacher B. [Recommendations of the Working Group of Arrhythmias of the German Society of Cardiology on the approach to patients with Riata® and Riata ST® leads (St. Jude Medical). Nucleus of the Working Group of Arrhythmias of the German Society of Cardiology]. Herzschrittmacherther Elektrophysiol. 2012 Jun;23(2):107-15. doi: 10.1007/s00399-012-0186-x. German.  Pott C, Eckardt L. Calcium is omnipresent in the physiology and pathophysiology of heart disease. Wien Med Wochenschr. 2012 Jul;162(13-14):277. doi: 10.1007/s10354-012-0126-8. No abstract available. Vogler J, Eckardt L. Pharmacology of myocardial calcium-handling. Wien Med Wochenschr. 2012 Jul;162(13-14):311-5. Epub 2012 Jun 16. Wasmer K, Mönnig G, Bittner A, Dechering D, Zellerhoff S, Milberg P, Köbe J, Eckardt L. Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation. Heart Rhythm. 2012 Oct;9(10):1660-6. doi: 10.1016/j.hrthm.2012.06.007. Epub 2012 Jun 6. Frommeyer G, Eckardt L, Milberg P.  Calcium handling and ventricular tachyarrhythmias. Wien Med Wochenschr. 2012 Jul;162(13-14):283-6. Epub 2012 Jun 7. Vogler J, Breithardt G, Eckardt L. Bradyarrhythmias and conduction blocks. Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):656-67. doi: 10.1016/j.recesp.2012.01.025. Epub 2012 May 23. Review. English, Spanish. Suttorp M, Eckardt L, Tauer JT, Millot F. Management of chronic myeloid leukemia in childhood. Curr Hematol Malig Rep. 2012 Jun;7(2):116-24. doi: 10.1007/s11899-012-0113-6. Review. Kaya E, Frommeyer G, Mönnig G, Eckardt L. Atrial fibrillation : new anticoagulants and antiarrhythmic drugs. Herz. 2012 Mar;37(2):159-65. doi: 10.1007/s00059-012-3589-x. German. Pott C, Muszynski A, Ruhe M, Bögeholz N, Schulte JS, Milberg P, Mönnig G, Fabritz L, Goldhaber JI, Breithardt G, Schmitz W, Philipson KD, Eckardt L, Kirchhof P, Müller FU. Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms. Basic Res Cardiol. 2012 Mar;107(2):247. doi: 10.1007/s00395-012-0247-7. Epub 2012 Feb 11. Mönnig G, Wasmer K, Milberg P, Schulz P, Köbe J, Zellerhoff S, Kochhäuser S, Pott C, Hindricks G, Borggrefe M, Breithardt G, Eckardt L. Predictors of long-term success after catheter ablation of atriofascicular accessory pathways. Heart Rhythm. 2012 May;9(5):704-8. doi: 10.1016/j.hrthm.2011.12.024. Epub 2011 Dec 31. Lebiedz P, Meiners J, Samol A, Wasmer K, Reinecke H, Waltenberger J, Eckardt L. Electrocardiographic changes during therapeutic hypothermia. Resuscitation. 2012 May;83(5):602-6. doi: 10.1016/j.resuscitation.2011.11.016. Epub 2011 Nov 25. Köbe J, Dechering DG, Rath B, Reinke F, Mönnig G, Wasmer K, Eckardt L. Prospective evaluation of electrocardiographic parameters in cardiac resynchronization therapy: detecting nonresponders by left ventricular pacing. Heart Rhythm. 2012 Apr;9(4):499-504. doi: 10.1016/j.hrthm.2011.11.009. Epub 2011 Nov 9. Milberg P, Pott C, Frommeyer G, Fink M, Ruhe M, Matsuda T, Baba A, Klocke R, Quang TH, Nikol S, Stypmann J, Osada N, Müller FU, Breithardt G, Noble D, Eckardt L. Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure. Heart Rhythm. 2012 Apr;9(4):570-8. doi: 10.1016/j.hrthm.2011.11.004. Epub 2011 Nov 7. Milberg P, Klocke R, Frommeyer G, Quang TH, Dieks K, Stypmann J, Osada N, Kuhlmann M, Fehr M, Milting H, Nikol S, Waltenberger J, Breithardt G, Eckardt L. G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure. Basic Res Cardiol. 2011 Nov;106(6):995-1008. doi: 10.1007/s00395-011-0230-8. Epub 2011 Nov 10. Köbe J, Reinke F, Dechering DG, Breithardt G, Eckardt L. Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone. Clin Res Cardiol. 2012 Mar;101(3):185-90. doi: 10.1007/s00392-011-0379-z. Epub 2011 Nov 5. Milberg P, Fink M, Pott C, Frommeyer G, Biertz J, Osada N, Stypmann J, Mönnig G, Koopmann M, Breithardt G, Eckardt L. Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure. Br J Pharmacol. 2012 May;166(2):557-68. doi: 10.1111/j.1476-5381.2011.01721.x. Mönnig G, Köbe J, Löher A, Wasmer K, Milberg P, Zellerhoff S, Pott C, Zumhagen S, Radu R, Scheld HH, Haverkamp W, Schulze-Bahr E, Eckardt L. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up. Europace. 2012 Mar;14(3):396-401. doi: 10.1093/europace/eur316. Epub 2011 Oct 6. Milberg P, Frommeyer G, Uphaus T, Kaiser D, Osada N, Breithardt G, Eckardt L. Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization. J Cardiovasc Pharmacol. 2012 Jan;59(1):92-100. doi: 10.1097/FJC.0b013e3182377a11.